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Pluripotent stem cells provide a powerful model for the study of human development and its disorders. Recent studies, including two in
this issue of Stem Cell Reports, raise important questions concerning the developmental potential of human pluripotent stem cells, and
how the behavior of these cells in vitro mirrors normal embryogenesis.

Human pluripotent stem cells
(hPSCs) grown under standard culture
conditions are often considered to
equate developmentally to mouse
primed epiblast stem cells, representing a state of pluripotency similar to
the late epiblast of the peri-gastrulation embryo. It is therefore somewhat
surprising that many reports have
confirmed that these archetypal
hPSCs are able to give rise to amnion
and primordial germ cells, since these
are lineages thought to arise from the
post-implantation epiblast very soon
after implantation (review, Pera and
Rossant, 2021). A cohort of recent
publications, including two in this
issue of Stem Cell Reports (Soncin
et al., 2022; Seetharam et al., 2022),
raises further fascinating questions
concerning the developmental potential of archetypal hPSCs.
In the mouse, the first three cell lineages of the mammalian conceptus—
trophoblast, epiblast, and primitive
endoderm—segregate prior to implantation, and there is no evidence that
the epiblast contributes to these lineages thereafter. In the human embryo,
the precise timing of trophoblast and
primitive endoderm specification
have been subject to some discussion,
but, as in the mouse, it has been
widely held that the two extraembryonic lineages are set aside before implantation. Largely for these reasons,
the finding (originally reported by
Ren-He Xu in James Thomson’s laboratory nearly 20 years ago; Xu et al.,
2002) that bone morphogenetic protein (BMP) 4 treatment of archetypal
hPSC can drive their differentiation

into trophoblast-like cells has long
been controversial. In fact, some
recent studies have suggested that
gene expression in the BMP-treated
archetypal hPSC cells resembles that
of amnion, rather than trophoblast
(Guo et al., 2021; Io et al., 2021). However, two reports in this issue, and
several other published reports and
pre-prints, collectively argue that conventional hPSCs indeed can differentiate into trophoblast cells.
Seetharam et al. (2022) surveyed
RNA sequencing (RNA-seq) data from
three published BMP differentiation
studies and compared them using a
placenta database and data from blastocyst and early embryo cultures.
They performed principal component
analysis across a range of experimental models of trophoblast and
amnion cells, and carried out cluster
analysis on single-cell RNA-seq
(scRNA-seq) studies of hPSC differentiation. The conclusions of this study
were that the BMP4 protocol
commonly used by most authors
indeed yields trophectoderm with a
bias toward syncytiotrophoblast formation. The authors also noted similarities in gene expression between
early trophoblast and amnion. Soncin
et al. (2022) use a modified BMP4based protocol to produce trophoblast
stem cells (TSCs) with properties
very similar to those of TSCs derived
directly from embryos, or from
naive pluripotent stem cells. These
TSCs could be differentiated into syncytiocytotrophoblast or extravillous
trophoblast, and produced trophoblast tumors when engrafted into im-

muno-deprived animals. scRNA-seq
analysis suggested a direct pathway
from the primed pluripotent state
through a trophoblast-like stage to
trophoblast stem cell, with no naive
cell-like intermediate.
Other recent studies support the
concept that archetypal hPSCs can
differentiate to the trophoblast lineage. Wei et al. (2021) showed that
BMP4 treatment could enhance generation of TSCs from primed hPSCs.
These TSCs could also form extravillous cytotrophoblasts and syncytiotrophoblasts. The authors documented a distinct epigenetic status of
TSCs. Their data showed some overlap
in amnion and trophoblast gene
expression, but ruled out the possibility that their cells were amnion. Jang
et al. (2022) also documented development of trophoblast stem celllike cells capable of differentiation
into functional extravillous trophoblast and syncytiotrophoblast from
archetypal hPSCs in the presence of
BMP4. Ohguishi and Eiraku (BioRxiv,
https://doi.org/10.1101/2021.06.28.
450118) showed that simply inhibiting activin and fibroblast growth factor (FGF) signaling could drive conversion of trophoblast stem cell-like cells
from primed hPSCs, through an
amnion-like intermediate. The cells
produced syncytia with gene expression consistent with syncytiotrophoblasts. The authors speculated that
amnion might be a source of syncytiotrophoblasts in primate development.
The likely source of amnion in
the primate post-implantation embryo has recently been examined by
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Rostovskaya et al. (2022) who surveyed transcriptomic data from
scRNA-seq experiments performed
on embryos, and followed this analysis up with experiments on hPSCs
in culture. These authors identified
two stages in primate amniogenesis,
the first originating from what the
authors called a partially primed
state, which proceeded through a
trophoblast-like intermediate to yield
amnion cells. These "first-wave"
amnion cells could participate in amniotic cavity morphogenesis. The second wave of amniogenesis was shown
to arise from what might be regarded
as a more conventional primed state
of pluripotency, one that differentiates toward amnion through a stage
resembling embryonic ectoderm.
This wave of amniogenesis was not
accompanied by cavitation. The authors contend that this second wave
accounts for the development of
amnion from conventional primed
hPSC cultures. This interpretation is
somewhat difficult to reconcile with
reports of amniotic cavity formation
by archetypal hPSCs (Shao et al.,
2017), but the finding of a trophoblast-like intermediate in early
amnion formation further highlights
the close relationship between intermediate cell states of both lineages.
How then should one interpret
these recent studies, along with the
previous work showing clearly that
archetypal hPSC cultures can differentiate into primordial germ cells and,
under some conditions, into cells
resembling primitive endoderm? It is
possible that cells similar to the
partially primed cells described by
Rostovskaya et al. (2022), equating to
early post-implantation epiblast, actually exist as a minority population in
archetypal hPSC cultures (review,
Pera and Rossant, 2021). Such cells
might retain some features of naive
pluripotent stem cells (which can

form trophoblast and extraembryonic
endoderm), while having also undergone capacitation to enable their
differentiation into amnion, the
germline, and somatic lineages. It is
also possible that the primate epiblast
displays considerably more developmental plasticity than its murine
counterpart, and retains the ability to
feed into extraembryonic and germ
layer lineages well past the early
post-implantation stage. Current
studies certainly suggest a close relationship between amnion and trophoblast lineages, and it may be that
epiblast trajectories between the two
are subject to enhanced plasticity under certain conditions in vitro and during development in the embryo.
These possibilities are not mutually
exclusive. Unraveling the lineage
pathways and fate decisions that primate epiblast-like cells follow in vitro
is absolutely critical for human embryo modeling and its application to
the study of early development and
its disorders. These recent studies
pose exciting challenges for future experiments to address.
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